The Colombian rider Nairo Quintana has been disqualified from the 2022 Tour de France after infringing an in-competition ban on utilizing the drug tramadol, the world biking governing physique (UCI) stated on Wednesday.
Quintana completed sixth within the normal classification for Group Arkea-Samsic in final month’s Tour, however evaluation of two dried blood samples revealed the presence of tramadol and its two important metabolites.
“In accordance with the UCI Medical Guidelines, the rider is disqualified from the 2022 Tour de France. This determination could also be appealed earlier than the Court docket of Arbitration for Sport (CAS) throughout the subsequent 10 days,” stated a UCI assertion.
“As this can be a first offence, Nairo Alexander Quintana Rojas will not be declared ineligible and may subsequently take part in competitions.”
Since 2019, utilizing tramadol has been an offence below the UCI Medical Guidelines as a result of side-effects of the substance that embody dizziness, drowsiness and lack of consideration. Testing optimistic for tramadol doesn’t represent a doping violation.
Tramadol has incessantly been utilized by skilled cyclists prior to now – figures from UK Anti-Doping state that between 2012 and 2019, 4.4% of in-competition assessments confirmed using the painkiller, whereas 68% of urine samples that contained Tramadol, from throughout 35 Olympic sports activities, have been from cyclists.